Correction to: Pharmacological inhibition of nSMase2 reduces brain exosome release and α-synuclein pathology in a Parkinson's disease model.

Autor: Zhu C; Drug Discovery Lab, Department of Neurology, University of California, Los Angeles, CA, 90095, USA., Bilousova T; Drug Discovery Lab, Department of Neurology, University of California, Los Angeles, CA, 90095, USA.; School of Nursing, University of California, Los Angeles, CA, 90095, USA., Focht S; Drug Discovery Lab, Department of Neurology, University of California, Los Angeles, CA, 90095, USA., Jun M; Drug Discovery Lab, Department of Neurology, University of California, Los Angeles, CA, 90095, USA., Elias CJ; Drug Discovery Lab, Department of Neurology, University of California, Los Angeles, CA, 90095, USA., Melnik M; Drug Discovery Lab, Department of Neurology, University of California, Los Angeles, CA, 90095, USA., Chandra S; Drug Discovery Lab, Department of Neurology, University of California, Los Angeles, CA, 90095, USA., Campagna J; Drug Discovery Lab, Department of Neurology, University of California, Los Angeles, CA, 90095, USA., Cohn W; Drug Discovery Lab, Department of Neurology, University of California, Los Angeles, CA, 90095, USA., Hatami A; Drug Discovery Lab, Department of Neurology, University of California, Los Angeles, CA, 90095, USA., Spilman P; Drug Discovery Lab, Department of Neurology, University of California, Los Angeles, CA, 90095, USA., Gylys KH; School of Nursing, University of California, Los Angeles, CA, 90095, USA., John V; Drug Discovery Lab, Department of Neurology, University of California, Los Angeles, CA, 90095, USA. VJohn@mednet.ucla.edu.
Jazyk: angličtina
Zdroj: Molecular brain [Mol Brain] 2021 Jul 08; Vol. 14 (1), pp. 108. Date of Electronic Publication: 2021 Jul 08.
DOI: 10.1186/s13041-021-00816-4
Databáze: MEDLINE